| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/08/2008 | CA2271126C Method of treating bronchitis with uridine triphosphates and related compounds |
| 04/08/2008 | CA2260909C Intestinal absorption of nicotine to treat nicotine responsive conditions |
| 04/08/2008 | CA2260315C 11-acetyl-12,13-dioxabicyclo[8.2.1]-tridecenone derivatives, processes for their preparation and pharmaceutical compositions comprising them |
| 04/08/2008 | CA2232663C At1-receptor antagonists for preventing and treating postischemic renal failure and for protecting ischemic kidneys |
| 04/08/2008 | CA2231342C Pharmaceutical composition for oral delivery |
| 04/08/2008 | CA2220188C Vinylpyrrolidinon cephalosporin derivatives |
| 04/08/2008 | CA2188924C Arylpiperidine and arylpiperazine derivatives and drugs containing the same |
| 04/08/2008 | CA2187541C Benzoxazepine derivatives, salts thereof, and drugs containing the same |
| 04/08/2008 | CA2182504C Process for the preparation of a salt of clavulanic acid |
| 04/06/2008 | CA2606042A1 Stop-and-go oxaliplatin treatment regimens |
| 04/06/2008 | CA2605902A1 Devices for reduction of post operative ileus |
| 04/06/2008 | CA2605791A1 Bioabsorbable device having encapsulated additives for accelerating degradation |
| 04/06/2008 | CA2605699A1 Bioabsorbable device having composite structure for accelerating degradation |
| 04/06/2008 | CA2562821A1 Composition and method for raising blood glucose level |
| 04/03/2008 | WO2008040009A1 Prostaglandin e2 (pge2) as an adjuvant in monoclonal antibody generation |
| 04/03/2008 | WO2008040002A2 Methods, compositions and articles of manufacture for hif modulating compounds |
| 04/03/2008 | WO2008040000A2 Soluble epoxide hydrolase inhibitors |
| 04/03/2008 | WO2008039999A1 Soluble epoxide hydrolase inhibitors |
| 04/03/2008 | WO2008039987A2 Methods of treating pulmonary distress |
| 04/03/2008 | WO2008039984A2 Methods and compositions for treating conditions by inhibiting cathepsin d |
| 04/03/2008 | WO2008039898A2 Methods for the treatment of a traumatic central nervous system injury |
| 04/03/2008 | WO2008039882A1 A combination of niacin and a prostaglandin d2 receptor antagonist |
| 04/03/2008 | WO2008039864A1 Emulsion formulations for transdermal delivery of poorly water soluble active agents |
| 04/03/2008 | WO2008039863A2 Composition comprising a melanocortin receptor (mcr) modulating agent alone or in combination with a second neurogenic agent for treating nervous system disorders |
| 04/03/2008 | WO2008039855A2 Nutrient sensor |
| 04/03/2008 | WO2008039829A2 Diphenylheterocycle cholesterol absorption inhibitors |
| 04/03/2008 | WO2008039827A2 Polymer systems for lung volume reduction therapy |
| 04/03/2008 | WO2008039794A1 Soluble epoxide hydrolase inhibitors |
| 04/03/2008 | WO2008039792A1 Stable pharmaceutical compositions of preserved formulation of ranitidine, process for making the same, and methods of their use |
| 04/03/2008 | WO2008039754A1 2-methylene-(20r,25s)-19,27-dinor-(22e)-vitamin d analogs |
| 04/03/2008 | WO2008039645A1 Compounds which modulate the cb2 receptor |
| 04/03/2008 | WO2008039642A2 Methods and compounds for treatment of clostridium based infection |
| 04/03/2008 | WO2008039641A2 Substituted phenylether-thienopyridone compounds with antibacterial activity |
| 04/03/2008 | WO2008039640A2 Enantiomeric compounds with antibacterial activity |
| 04/03/2008 | WO2008039639A2 Substituted thienopyridone compounds with antibacterial activity |
| 04/03/2008 | WO2008039615A2 Controlled release hydrogel formulation |
| 04/03/2008 | WO2008039566A2 Drugs and uses |
| 04/03/2008 | WO2008039514A1 Pharmaceutical compositions and methods for treating diseases associated with neurodegeneration |
| 04/03/2008 | WO2008039489A2 5-substituted quinazolinone derivatives as antitumor agents |
| 04/03/2008 | WO2008039482A2 Methods and compositions for cancer prevention and treatment |
| 04/03/2008 | WO2008039473A2 Alcohol free formulation of argatroban |
| 04/03/2008 | WO2008039472A2 Stabilizing compositions for antibiotics and methods of use |
| 04/03/2008 | WO2008039431A2 Crystalline forms of 3-[5-(2-fhjorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid |
| 04/03/2008 | WO2008039421A2 Pharmaceutical compositions of hdac inhibitors and chelatable metal compounds, and metal-hdac inhibitor chelate complexes |
| 04/03/2008 | WO2008039420A2 Novel inhibitors of beta-lactamase |
| 04/03/2008 | WO2008039418A2 Acylated piperidine derivatives as melanocortin-4 receptor modulators |
| 04/03/2008 | WO2008039409A2 Methods and kits for use in the treatment and prevention of diseases or conditions of the immune system or infectious diseases |
| 04/03/2008 | WO2008039359A2 Bicyclic pyrimidine kinase inhibitors |
| 04/03/2008 | WO2008039358A2 Resin-complex granulation for water-soluble drugs and associated methods |
| 04/03/2008 | WO2008039327A2 Method of treatment using fatty acid synthesis inhibitors |
| 04/03/2008 | WO2008039218A2 Inhibitors of bruton's tyrosine kinase |
| 04/03/2008 | WO2008039200A1 Methods and compositions for treating lymphoma and myeloma |
| 04/03/2008 | WO2008039179A1 Compositions for the treatment of hepatitis c and methods for using compositions for the treatment of hepatitis c |
| 04/03/2008 | WO2008039139A1 Novel 5,7-disubstituted [1, 3] thiazolo [4, 5] pyrimidin-2 (3h)-amine derivatives and their use in therapy |
| 04/03/2008 | WO2008039138A1 Novel 5, 7-disubstituted [1, 3 ] thiazolo [4, 5-d] pyrimidin-2 (3h)-one derivatives and their use in therapy |
| 04/03/2008 | WO2008039051A1 Pharmaceutical composition for treating the excess weight and obesity which accompany dyslipidaemia |
| 04/03/2008 | WO2008039023A1 Heteroaryl-pyrazole derivatives as cannabinoid cb1 receptor antagonists |
| 04/03/2008 | WO2008039008A1 Composition for the prevention and treatment of metabolic disorder containing benzazole derivatives as an active ingredient |
| 04/03/2008 | WO2008038973A1 A pharmaceutical composition comprising cordycepin for the treatment and prevention of obesity |
| 04/03/2008 | WO2008038955A1 Benzophenone derivatives useful for inhibiting formation of microtubule |
| 04/03/2008 | WO2008038841A1 Thiadiazolone derivative and use thereof |
| 04/03/2008 | WO2008038832A1 Therapeutic agent, detection method and detection kit for breast cancer and ovarian cancer |
| 04/03/2008 | WO2008038807A1 External composition for skin |
| 04/03/2008 | WO2008038806A1 Antipruritic agent |
| 04/03/2008 | WO2008038771A1 Glutamine-containing composition for increasing blood flow |
| 04/03/2008 | WO2008038768A1 Compound having bicyclic pyrimidine structure and pharmaceutical composition comprising the compound |
| 04/03/2008 | WO2008038712A1 Therapeutic/prophylactic agent for metabolic syndrome |
| 04/03/2008 | WO2008038711A1 Oxepin derivative |
| 04/03/2008 | WO2008038692A1 Diaryl ketimine derivative |
| 04/03/2008 | WO2008038600A1 1,4-benzodiazepine derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes |
| 04/03/2008 | WO2008038423A1 Antiphlogistc and analgetic composition for oral use |
| 04/03/2008 | WO2008038417A1 Cardiovascular preparation |
| 04/03/2008 | WO2008038394A1 Musclin receptor and use thereof |
| 04/03/2008 | WO2008038305A2 Therapeutical formulation comprising a thiazolidinedione and a nitric oxide scavenger. |
| 04/03/2008 | WO2008038304A2 Therapeutical formulation comprising an alpha-glucosidase inhibitor and a nitric oxide scavenger. |
| 04/03/2008 | WO2008038303A2 Therapeutic formulation comprising a sulfonylurea, a thiazolidinedione and a nitric oxide scavenger. |
| 04/03/2008 | WO2008038302A2 Therapeutic formulation comprising a sulfonylurea, metformin and a nitric oxide scavenger. |
| 04/03/2008 | WO2008038299A1 Substituted 6-(1-aryl ethyl)-i, 2, 4-trioxanes |
| 04/03/2008 | WO2008038292A2 Use of glycerophospholipids for joint lubrication |
| 04/03/2008 | WO2008038291A1 Combination of liposomal anti-cancer drugs and lysosome/endosome ph increasing agents for therapy |
| 04/03/2008 | WO2008038251A2 3-aza-bicyclo[3.1.0]hexane derivatives |
| 04/03/2008 | WO2008038175A2 Dithiolopyrrolones compounds and their therapeutic applications |
| 04/03/2008 | WO2008038155A2 Controlled-release pharmaceutical tablets |
| 04/03/2008 | WO2008038134A1 Method for preparing chitosan nano-particles |
| 04/03/2008 | WO2008038111A1 Dextran functionalized with hydrophobic amino acids |
| 04/03/2008 | WO2008038106A1 Venlafaxine extended release formulations |
| 04/03/2008 | WO2008038053A1 Ion channel modulators & uses thereof |
| 04/03/2008 | WO2008038051A2 Use of ion channel modulators in the prophylaxis and treatment of inflammatory and immunological diseases |
| 04/03/2008 | WO2008038031A1 An improved process for the preparation of temozolomide and analogs |
| 04/03/2008 | WO2008038030A2 Dispiro tetraoxane compounds and their use in the treatment of malaria and/or cancer |
| 04/03/2008 | WO2008038018A1 Novel minor groove binders |
| 04/03/2008 | WO2008038011A1 Pyrimidine derivatives as aurora a and aurora b inhibitors |
| 04/03/2008 | WO2008038010A1 Pyrazine derivatives and their use in therapy |
| 04/03/2008 | WO2008038003A2 Pharmaceutical compositions of aripiprazole |
| 04/03/2008 | WO2008037996A1 Combination of zd6474 and bevacizumab for cancer therapy |
| 04/03/2008 | WO2008037937A2 Use of compounds of the milbemycin family for the treatment of dermatological disorders in human beings |
| 04/03/2008 | WO2008037936A1 Use of compounds of the milbemycin family for the treatment of dermatological disorders in human beings |
| 04/03/2008 | WO2008037935A2 Use of 6'-ethyl-lepimectine, 6'-methyl-lepimectine or derivatives thereof for the treatment of dermatological disorders in human beings |
| 04/03/2008 | WO2008037934A1 Use of compounds of the avermectin family for the treatment of dermatological disorders in human beings |
| 04/03/2008 | WO2008037933A1 Use of compounds of the avermectin family for the treatment of dermatological disorders in human beings |